期刊文献+

NOX1和NOX4在小鼠非酒精性脂肪性肝炎发病中的作用 被引量:1

Role of NOX1 and NOX3 in mice with Non-alcoholic steatohepatitis
暂未订购
导出
摘要 目的探讨NOX1和NOX4在小鼠非酒精性脂肪性肝炎(NASH)发病中的作用。方法给予C57BL小鼠高脂饮食及脂多糖建立非酒精性脂肪肝模型,同时设立正常饮食组作为对照。观察各组小鼠血清ALT、AST值,HE染色评定脂肪性肝炎程度,实时荧光定量反转录-聚合酶链反应检测NOX1、NOX4mRNA的表达水平。结果非酒精性脂肪性肝炎模型建立成功,NASH模型组小鼠ALT、AST及肝指数明显高于高脂(HF)组(P<0.05),HF组NOX1、NOX4mRNA表达高于正常对照组(P<0.05),NASH组的NOX1、NOX4mRNA表达明显高于正常对照组和HF组(P<0.01)。结论本实验初步认为,NOX1和NOX4参与胰岛素抵抗的形成,可能是影响NASH发生和发展的重要因素。 Objective To explore the role of NOX1 and NOX4 in mice with non - alcoholic steatohepatitis (NASH). Methods High fat diet and lipopolysaccharide were given to C57BL mice in order to establish NASH model, while the control group only received normal diet. Serum alanine and aspartate aminotransferase (ALT and AST) levels were observed. Real- time FQ -PCR method was used for testing of expression levels of NOXI and NOX4 mRNA. Results Model of NASH mouse was successfully established, ALT level, AST level and liver index in NASH group were higher than HF group (P 〈 0.05 ) , and expression of NOX 1 and NOX4 mRNA in HF group was higher than the control group(P 〈0.05) , furthermore among the 3 groups, expression of NOX1 and NOX4 mRNA in NASH group was the highest (P 〈 0.01 ). Conclusions The research proves that NOX1 and NOX4 partici- pate in the formation of insulin resistance, and this may be an important factor in the occurrence and development of NASH.
出处 《实用临床医药杂志》 CAS 2012年第23期5-8,共4页 Journal of Clinical Medicine in Practice
基金 上海市卫生局课题(编号:2009232)
关键词 非酒精性脂肪性肝炎 NOX1 NOX4 C57BL小鼠 non - alcoholic steatohepatitis NOX1 NOX4 C57BL mouse
  • 相关文献

参考文献2

二级参考文献132

  • 1Shiro Yokohama,Yoshihiko Tokusashi,Kimihide Nakamura,Yosui Tamaki,Satoshi Okamoto,Mituyoshi Okada,Kazunobu Aso,Takenao Hasegawa,Masaru Aoshima,Naoyuki Miyokawa,Masakazu Haneda,Masashi Yoneda.Inhibitory effect of angiotensinⅡreceptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis[J].World Journal of Gastroenterology,2006,12(2):322-326. 被引量:10
  • 2Jaskiewicz K.,Raczynska S.,Rzepko R.,Sledziński Z,纪泛扑.胃成形术治疗肥胖者的非酒精性脂肪性肝病[J].世界核心医学期刊文摘(胃肠病学分册),2006,2(6):4-5. 被引量:1
  • 3[1]Kleiner DE,Brunt EM,Van Natta M,Behling C,Contos MJ,Cummings OW,Ferrell LD,Liu YC,Torbenson MS,Unalp-Arida A,Yeh M,McCullough AJ,Sanyal AJ.Design and validation of a histological scoring system for nonalcoholic fatty liver disease.Hepatology 2005;41:1313-1321
  • 4[2]Browning JD,Szczepaniak LS,Dobbins R,Nuremberg P,Horton JD,Cohen JC,Grundy SM,Hobbs HH.Prevalence of hepatic steatosis in an urban population in the United States:impact of ethnicity.Hepatology 2004;40:1387-1395
  • 5[3]Schwimmer JB,Deutsch R,Kahen T,Lavine JE,Stanley C,Behling C.Prevalence of fatty liver in children and adolescents.Pediatrics 2006;118:1388-1393
  • 6[4]Marchesini G,Bugianesi E,Forlani G,Cerrelli F,Lenzi M,Manini R,Natale S,Vanni E,Villanova N,Melchionda N,Rizzetto M.Nonalcoholic fatty liver,steatohepatitis,and the metabolic syndrome.Hepatology 2003;37:917-923
  • 7[5]Neuschwander-Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology 2003;37:1202-1219
  • 8[6]Angulo P.Nonalcoholic fatty liver disease.N Engl J Med 2002;346:1221-1231
  • 9[7]Adams LA,Lymp JF,St Sauver J,Sanderson SO,Lindor KD,Feldstein A,Angulo P.The natural history of nonalcoholic fatty liver disease:a population-based cohort study.Gastroenterology 2005;129:113-121
  • 10[8]Matteoni CA,Younossi ZM,Gramlich T,Boparai N,Liu YC,McCullough AJ.Nonalcoholic fatty liver disease:a spectrum of clinical and pathological severity.Gastroenterology 1999;116:1413-1419

共引文献104

同被引文献30

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部